What does INTENSITY THERAPEUTICS, INC. do?

INTENSITY THERAPEUTICS, INC. is a public company in the Biological Products, (No Diagnostic Substances) industry, incorporated in DE. It is registered with the SEC under CIK 0001567264 and trades on NASDAQ under the ticker INTS.

Is INTENSITY THERAPEUTICS, INC. profitable?

INTENSITY THERAPEUTICS, INC. reported a net loss of $11.61M in FY2025. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has INTENSITY THERAPEUTICS, INC. made?

INTENSITY THERAPEUTICS, INC. has filed 225 documents with the SEC since 2013. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

INTENSITY THERAPEUTICS, INC.

INTS NASDAQ CIK: 0001567264 Biological Products, (No Diagnostic Substances) Inc. in DE

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 225 filings →

Form	Description	Date
8-K	8-K	Mar 27, 2026
10-K	10-K	Mar 27, 2026
8-K	8-K	Mar 23, 2026
424B5	424B5	Mar 23, 2026
8-K	8-K	Mar 6, 2026
8-K	8-K	Mar 5, 2026
8-K	8-K	Feb 13, 2026
S-8	S-8	Jan 23, 2026
4	FORM 4	Jan 5, 2026
4	FORM 4	Jan 5, 2026

Insider Transactions

View all →

Insider	Title	Type	Shares	Owns After	Date
Wesolowski John M	Principal Accounting Officer	Award / Grant	69,745 @ $0.26	76,436	Jun 30, 2025
Talamo Joseph	Chief Financial Officer	Award / Grant	14,179 @ $0.26	14,179	Jun 30, 2025

About This Profile

This page aggregates all publicly available SEC EDGAR data for INTENSITY THERAPEUTICS, INC.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Net Income: ($11.61M) (FY2025)
Total Assets: $14.10M (FY2025)
Operating Income: ($11.97M)

Full financials →

Details

CIK: 0001567264
Ticker: INTS
Exchange: NASDAQ
Incorporated: DE
First Filing: 2013
Total Filings: 225

Biological Products, (No Diagnostic Substances) rankings →